VIDEO from European Parliament Available on thenewsmarket.com: S&D Call for Immediate EU-wide Ban on 'Export of Death'
NEW YORK, Jan. 25, 2011 /PRNewswire/ -- See video from European Parliament at:
An immediate EU-wide ban on the export of lethal injection drugs was called today in Brussels after British NGO Reprieve revealed that a UK based company, Dream Pharma, supplied the state of Arizona with the drugs needed for an execution. Claude Moraes, S&D spokesperson on civil liberties, called on European Commission vice president Vivianne Reding, in charge of fundamental rights, and on international trade commissioner, Karel De Gucht, to reaffirm the EU's fierce rejection of any support of death penalty and to promote a EU-wide ban on this unacceptable export of death. "We should call for a Council intervention, we should call for the commissioners for fundamental rights and for trade to move very quickly, not just because these are awful situations of, you know, on the one hand not having the death penalty in the EU but exporting it, but also because this is a symbolic value of the European union," he said. According to Clive Stafford Smith, the director of British NGO Reprieve, which has been denouncing Dream Pharma's activities since last October, it is now sure that Dream Pharma has exported drugs to at least 4 states, and sufficient to kill more than 100 people. "One of the frustrating aspects of this is that a week after we head off the British government to impose an export ban, Dream Pharma went ahead and exported another shipment of drugs sufficient to kill about 80 people. So we could have stopped that if only the government had moved quickly enough," Smith said. "It is very important that the European Parliament acts very quickly and Europe commission because that's really the only way to stop drugs coming from anywhere else out Europe. Otherwise they can send it from Britain to other countries in Europe and then it goes on to America," he added. Dream Pharma is a pharmaceutical company run by Matt Alavi. On January 6, Reprieve released documentary proof that the Acton-based company sold drugs to Arizona that were used in the execution of Jeffrey Landrigan on October 26th, 2010, and that will send many other prisoners to their deaths. Mr. Alavi sold 150 vials of sodium thiopental, 180 vials of potassium chloride, and 450 vials of pancuronium bromide to the Arizona State Prison on September 28th, 2010. This was sufficient to execute at least ten prisoners, and one has already died as a result. The sodium thiopental was sold for 1,180.50 pounds, a significant mark-up over the normal price in the US. The State of Arizona sought permission from the state supreme court on December 28th to go forward with the next prisoners in line for execution. Reprieve also revealed that before Arizona, the State of Arkansas bought drugs from the UK, though the precise quantity is not yet known. Furthermore, on 6th January an additional 1,042 vials of sodium thiopental (sufficient to execute 85 prisoners) were released to California by the US Food & Drug Administration (FDA), after importation from Dream Pharma on November 5th. Drugs bought by various states are thought to have been sourced from Dream Pharma, although the company has declined to confirm the fact, or produce the invoices. Various other states' recent purchases of execution drugs from the UK remain secret.
About thenewsmarket.com
thenewsmarket.com delivers free broadcast- and streaming-quality video and multimedia content directly to media around the world, 24/7. More than 25,000 media outlets in 190+ countries use thenewsmarket.com, including the AP, BBC, CNBC, CNN, France 24, N24, nytimes.com, RAI, TVE, ZDF and a lot more.
Registered journalists can preview and download video, audio, text, graphics and photos at http://www.thenewsmarket.com.
If not already registered, please take a moment to sign up - registration is quick, easy and free: http://www.thenewsmarket.com/registration
We are always happy to receive your feedback, suggestions or enquiries. Email us at [email protected]
Story Id: 21371
SOURCE thenewsmarket.com
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article